Epidemiology and Laboratory Capacity funding in Oregon

Three awards define the Oregon × ELC pair

The pair reported here is CFDA 93.323 (EPIDEMIOLOGY AND LABORATORY CAPACITY FOR INFECTIOUS DISEASES (ELC)) crossed with Oregon as place of performance. $539,116,264.91 is the obligation sum on records that match both keys. The national 93.323 program page includes every state. The Oregon spending page includes every CFDA. This tie is the intersection only. Open Epidemiology And Laboratory Capacity For Infectious Diseases (Elc) in Oregon for the overlay of those 3 awards.

ELC assistance typically posts as a small number of large awards to a state health department or its designated laboratory partners. Three awards is an extremely concentrated count. The join still does not identify the three recipients, the award IDs, the pathogens covered, or the fiscal years of those records; those fields are absent from the packet facts. A large ELC total does not prove that Oregon had more disease burden than another state, because no other-state figures appear here.

CFDA 93.323 is one HHS/CDC catalog line. Other infectious-disease, immunization, and hospital-preparedness programs use other numbers and appear on other Oregon program pages. Collapsing those catalogs into this $539,116,264.91 cell would invent a total the facts do not support. Correlation is not causation.

How to read a $179.7 million mean

About $179,705,422 per award ($539,116,264.91 ÷ 3) is a mean of three large instruments, not a typical county health-department grant. A mean with n = 3 is dominated by whichever award is largest; it is not a median and not a cost per test. The aggregate reports net obligations supplied in the facts. Amendments and downward modifications, if present in the raw file, are already netted into $539,116,264.91 rather than shown as a separate column.

Cite both columns. High dollars with a three-row award count are a signature of capacity-building assistance to a state, not evidence of a single equipment purchase. USAspending.gov is the source. SpendingVault does not recast the mean as a lab invoice.

Oregon geography versus statewide HHS spending

Place of performance Oregon means USAspending tagged the award to OR. It does not itemize Portland versus rural counties, and it does not prove that every subcontract stayed in-state. Awards tagged to other states are outside this cell even if Oregon laboratories later received specimens or transfers. The Oregon federal spending hub remains the parent for all programs. Treating $539,116,264.91 as the state’s complete federal health footprint would ignore every other CFDA on the Oregon programs list. Three awards can still be statewide instruments; the extract does not prove they are county-level lab contracts.

FEC filings do not finance this USAspending cell. Donor geography and award geography are different public-record systems. This page does not rank Oregon’s ELC cell against other states.

Obligations are not laboratory outlays

The $539,116,264.91 figure is an obligation sum. Cash drawn for epidemiology staffing, lab equipment, or data systems can trail the obligation. This page does not publish a 93.323-in-Oregon outlay total. Mixing case counts, positivity rates, or hospital occupancy with this award file leaves the USAspending series the aggregate actually reports. ELC is a capacity catalog; the three-award cell is not a disease-burden ranking.

Cite the join as CFDA 93.323 × Oregon, $539,116,264.91, 3 awards, obligations only.

Tables behind the ELC tie

Use Epidemiology And Laboratory Capacity For Infectious Diseases (Elc) in Oregon for the overlay rows that still sum to $539,116,264.91 on 3 awards. Recipient slices on that hub still add toward the same two facts. CFDA 93.323 is the national catalog parent. Oregon federal spending and Oregon programs are the statewide parents. All spending ties lists other program–place pairs on the same basis.

None of those links convert the cell into a disease-incidence ranking or into outlays this packet omits.

Questions

How much ELC infectious-disease funding is obligated in Oregon?

USAspending records $539,116,264.91 in CFDA 93.323 obligations with Oregon place of performance across 3 awards. That figure is an obligation aggregate for this pair, not an outlay and not every HHS health CFDA in the state.

Why are there only 3 awards for $539 million?

The packet facts show 3 awards totaling $539,116,264.91. ELC capacity assistance often posts a few large awards to a state health department rather than thousands of small lab invoices. The mean is about $179,705,422 per award; the facts do not name the recipients.

Is CFDA 93.323 the same as all Oregon public-health federal spending?

No. This join is limited to Epidemiology and Laboratory Capacity for Infectious Diseases (ELC). Other health catalogs use other CFDA numbers and sit on separate Oregon program pages. $539,116,264.91 on 3 awards is the 93.323 × Oregon cell only, not a combined HHS total.

Are these obligations the same as money spent on labs?

No. USAspending obligations are commitments, not outlays. The $539,116,264.91 total is the obligation sum in the aggregate, not a proof of cash disbursed or tests performed. This page does not publish an Oregon 93.323 outlay column.